Mustafa Khasraw, MD
Duke University · Barwon Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mustafa Khasraw, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:32 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06069726 · A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB TrialDuke University · recruiting · Recurrent Glioblastoma · principal investigator
- Ph2NCT02215447 · A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasBarwon Health · unknown · Gastrointestinal Neuroendocrine Carcinomas · study chair
- Ph2NCT01830244 · IST Neoadjuvant Abraxane in Newly Diagnosed Breast CancerBarwon Health · unknown · Breast Cancer · principal investigator
- N/ANCT01486459 · A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung CancerBarwon Health · terminated · Small Cell Lung Cancer · principal investigator
- Ph1NCT00626483 · Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused LymphopeniaGary Archer Ph.D. · completed · Malignant Neoplasms Brain · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:32 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- P50CA108786RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00626483
- Cancer Biology ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI Ann Marie Pendergast · fiscal years 2015 to 2026Named on NCT00626483
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.